Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

28,000

Employees28,000

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

28,000

Employees28,000

AMGN Key Statistics

Market cap

162.76B

Market cap162.76B

Price-Earnings ratio

39.41

Price-Earnings ratio39.41

Dividend yield

3.02%

Dividend yield3.02%

Average volume

2.67M

Average volume2.67M

High today

$305.33

High today$305.33

Low today

$294.00

Low today$294.00

Open price

$299.73

Open price$299.73

Volume

3.26M

Volume3.26M

52 Week high

$346.85

52 Week high$346.85

52 Week low

$253.30

52 Week low$253.30

AMGN News

Seeking Alpha 21h

Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara

Teva Pharmaceutical (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) have launched their biosimilar targeting Johnson & Johnson’s (NYSE:JNJ) blockbuster arthritis therapy...

Simply Wall St 6d

This Insider Has Just Sold Shares In Amgen

We wouldn't blame Amgen Inc. ( ) shareholders if they were a little worried about the fact that Murdo Gordon, the Executive Vice President of Global Commercial...

Analyst ratings

47%

of 32 ratings

Buy

46.9%

Hold

43.8%

Sell

9.4%